about
Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell line, A7r5.Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies.Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells.The effect of bone marrow- and adipose tissue-derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure.Protein kinase M zeta regulation of Na/K ATPase: a persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures.WISP1 is a novel adipokine linked to inflammation in obesity.[Lamin A/C mutations change differentiation potential of mesenchymal stem cells].Genetic Control of Serum Marinobufagenin in the Spontaneously Hypertensive Rat and the Relationship to Blood Pressure.New Approach to Cryopreservation of Primary Noncultivated Human Umbilical Vein Endothelium in Biobanking.Lamin A/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling.Various lamin A/C mutations alter expression profile of mesenchymal stem cells in mutation specific manner.Association of tribbles homologue 1 gene expression in human umbilical vein endothelial cells with duration of intrauterine exposure to hyperglycaemia.[Nuclear lamins regulate osteogenic differentiation of mesenchymal stem cells].Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations[Comparative assessment of different approaches for obtaining terminally differentiated muscle cells]Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: Differences and similaritiesVasorelaxant effects of cicletanine and its (+)- and (−)-enantiomers in isolated human pulmonary arteriesEndogenous marinobufagenin-like immunoreactive substance*A possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activityEffects of two endogenous Na+,K+-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aortaPlasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogsClinical Response to Personalized Exercise Therapy in Heart Failure Patients with Reduced Ejection Fraction is Accompanied by Skeletal Muscle Histological Alterations
P50
Q40613366-294DAA89-5E2C-4E14-BF74-DFB12C398D86Q42017721-0BB1A7BD-0D3F-46CC-A725-3B8CC9C797D3Q44433293-61881D3B-96C9-44E9-B350-BCDE59D49C96Q44494668-9CA1F045-AF7F-4285-A5DD-1BDB7896B00BQ46248473-5B79B287-9A8B-44F3-B897-86A46D5D9F0BQ46470587-E1ECBD0D-0749-42BC-A698-87D4A1D3F80BQ46557680-7E155771-F257-4AA1-BF52-C78C2620F816Q47148325-DDFA7F6C-E3F4-4D86-BBB6-78537F09D2DBQ47715091-9F1AF807-F073-45D9-8E41-741B1C1CE50EQ50081196-00B77A47-E00C-4DE1-996D-F257A6D298C2Q50852448-7D6FD8EE-20E6-4477-8CEB-F8FC87072BD2Q52729044-868099EE-DBBC-4574-9796-3D4C9DB887E1Q52992565-784EB52B-A685-4FC9-A2F3-5DABB8F2EC9DQ54426625-75727ACA-AA5F-4115-A24E-EFE611C05D5DQ61807366-D8FFF261-A1DF-4144-8F06-7BE794B9C0C8Q62633171-A3382706-A2E1-441D-8D91-B42CF78EE281Q62633212-7E312952-1922-4558-8489-450C77194424Q62633242-3779420F-72B1-4941-9553-DA50081C0325Q62633250-3BDB5267-6139-4117-9D1E-A02740610117Q62633265-558B5956-1390-491C-97BB-DFFE65C5C4B4Q71322851-2487265D-7B88-4F9C-96B3-6EB885CC2CE2Q91147909-1B0A6912-49D5-4ECF-BB82-8C0DF52160C4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Renata I. Dmitrieva
@ast
Renata I. Dmitrieva
@en
Renata I. Dmitrieva
@es
Renata I. Dmitrieva
@sl
type
label
Renata I. Dmitrieva
@ast
Renata I. Dmitrieva
@en
Renata I. Dmitrieva
@es
Renata I. Dmitrieva
@sl
prefLabel
Renata I. Dmitrieva
@ast
Renata I. Dmitrieva
@en
Renata I. Dmitrieva
@es
Renata I. Dmitrieva
@sl
P106
P1153
7004124687
P21
P31
P496
0000-0002-3073-7914